Bilfinger SE

  • WKN: 590900
  • ISIN: DE0005909006
  • Land: Deutschland

Nachricht vom 09.07.2018 | 15:04

Bilfinger SE: Release of a capital market information

Bilfinger SE / Disclosure according to Art. 5 para. 1(b), para 3 of
Regulation (EU) No. 596/2014 in connection with Art. 2 para. 2 and 3 of
Delegated Regulation (EU) 2016/1052 Share buyback - 44th Interim Reporting

09.07.2018 / 15:04
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Bilfinger SE: Share buyback In the time period from July 2, 2018 until and including July 6, 2018, a number of 49,618 shares were bought back within the framework of the share buyback of Bilfinger SE. The beginning of the share buyback on September 6, 2017 was disclosed on September 1, 2017 pursuant to Art. 5 para. 1 of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Day of purchase Aggregated volume in Average price shares [EUR] 2. July 2018 9,950 43.2257 3. July 2018 9,870 43.5664 4. July 2018 9,934 43.2850 5. July 2018 9,956 43.1870 6. July 2018 9,908 43.3957 The transactions are published in a detailed form on the website of Bilfinger SE(http://www.bilfinger.com). The total volume of shares which have been bought back within the framework of the share buyback in the time period of September 6, 2017 until and including July 6, 2018, amounts to 2,639,862 shares. The purchase of the shares of Bilfinger SE is carried out exclusively via the stock exchange (Xetra) by a bank commissioned by Bilfinger SE.
09.07.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language: English Company: Bilfinger SE Carl-Reiß-Platz 1-5 68165 Mannheim Germany Internet: http://www.bilfinger.com End of News DGAP News Service

GBC-Fokusbox

UniDevice AG: Rekord-Ergebnis in 2018

Nach starkem Schlussspurt hat die UniDevice AG in 2018 Umsatz und Ergebnis deutlich gesteigert. Der B2B-Broker für hochpreisige Smartphones sollte auch künftig eine hohe Nachfrage verzeichnen und von der Ausnutzung unterschiedlicher Preisniveaus in den verschiedenen Ländern profitieren. Der Umsatz soll 2019 auf mindestens 380 Mio. € und in 2020 auf mindestens 410 Mio. € ansteigen, nachdem 2018 317 Mio. € erreicht wurden. Bei einem ermittelten Kursziel in Höhe von 2,35 € lautet das Rating KAUFEN.

News im Fokus

Fresenius Medical Care veröffentlicht Form 20-F für das Geschäftsjahr 2018

21. Februar 2019, 11:51

Aktueller Webcast

Ströer SE & Co. KGaA

Vorläufige Geschäftszahlen 2018

26. Februar 2019

Aktuelle Research-Studie

Sanochemia Pharmazeutika AG

Original-Research: Sanochemia Pharmazeutika AG (von Sphene Capital GmbH): Buy

21. Februar 2019